342 A Phase Ib/II study of alpelisib (BYL719) and ganitumab (AMG 479) in adult patients with selected advanced solid tumors

Title
342 A Phase Ib/II study of alpelisib (BYL719) and ganitumab (AMG 479) in adult patients with selected advanced solid tumors
Authors
Keywords
-
Journal
EUROPEAN JOURNAL OF CANCER
Volume 51, Issue -, Pages S68
Publisher
Elsevier BV
Online
2016-02-09
DOI
10.1016/s0959-8049(16)30205-2

Ask authors/readers for more resources

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started